Collagenase Option for Reduction of Dupuytren's Contracture in Japan

NCT01588353 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Dupuytren's Contracture

Interventions

DRUG: Collagenase Clostridium Histolyticum

Sponsor

Asahi Kasei Therapeutics Corporation